Generic placeholder image

Recent Patents on Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-891X
ISSN (Online): 2212-4071

Antibiotic Treatment Strategies for Helicobacter pylori Infection

Author(s): S.M. A. Campo, A. Zullo, C. Hassan and S. Morini

Volume 2, Issue 1, 2007

Page: [11 - 17] Pages: 7

DOI: 10.2174/157489107779561706

Price: $65

Abstract

In the third decade of the Helicobacter pylori era several informations are available on its pathogenetic mechanisms, as well as on therapeutic approaches. A 7-14 day triple or quadruple regimens (proton pump inhibitor together with 2 antibiotics) are currently suggested as first-line treatment, but the success rate following these therapy is constantly decreasing worldwide. Therefore, new drugs are needed to treat such a widespread infection. Several patents of new antibiotics have been claimed in the last 5 years, and some of them showed a very powerful antibacterial activity in vitro, even against clarithromycin and metronidazole resistant strains. Among the new compounds, thienylthiazole derivatives, benzamide derivatives and pyloricidins should be regarded as very promising molecules.

Keywords: Antibiotics, Helicobacter pylori, therapy


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy